Career Development Awards: New Investigator


2003 (Cycle IX)

  Top
Role of Oxidative DNA Damage to Breast Tumor Progression
Award: $588,555
Institution: Lawrence Livermore National Laboratory Subject Area: Pathogenesis
The Hygiene Hypothesis and Breast Cancer Risk
Award: $366,955
Institution: Cancer Prevention Institute of California Subject Area: Etiology
Common Genetic Variation & Breast Cancer: A Genomic Approach
Award: $462,925
Institution: University of Southern California Subject Area: Prevention & Risk Reduction

2002 (Cycle VIII)

  Top
Studies of Telomere Capping Dysfunction in Breast Cancer
Award: $117,712
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Understanding Aging Effects in the Breast
Award: $448,730
Institution: Lawrence Berkeley National Laboratory Subject Area: Biology of the Normal Breast
Impact of Breast Cancer and its Therapy on Bone Density
Award: $300,000
Institution: University of California, Los Angeles Subject Area: Health Policy & Health Services
The Role of PTEN in Progression of Ductal Carcinoma in situ
Award: $305,507
Institution: Cedars-Sinai Medical Center Subject Area: Pathogenesis
Locating Novel Breast Cancer Genes using DNA Microarrays
Award: $477,295
Institution: Stanford University Subject Area: Pathogenesis

2001 (Cycle VII)

  Top
Enhanced HER-2 Directed Liposomal Therapeutics
Award: $332,938
Institution: California Pacific Medical Center Research Institute Subject Area: Innovative Treatments
Enhanced HER-2 Directed Liposomal Therapeutics
Award: $131,823
Institution: Hermes Biosciences, Inc. Subject Area: Innovative Treatments
Tumor Suppression by Dystroglycan in Breast Epithelial Cells
Award: $302,190
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Pathway-Specific Gene Expression in Breast Cancer Cells
Award: $339,287
Institution: University of California, Davis Subject Area: Pathogenesis
The Functions of BRCA2 in Repairing DNA Damage
Award: $485,757
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Patient-Individualized Chemotherapy in Breast Cancer
Award: $296,994
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Trypsin-like Proteases as Metastatic Agents in Breast Cancer
Award: $295,893
Institution: University of California, Riverside Subject Area: Pathogenesis
The PTEN/Akt Pathway in Ductal Carcinoma In Situ
Award: $99,604
Institution: Cedars-Sinai Medical Center Subject Area: Pathogenesis
Role of Vitamin D Receptor and PI3k Genes in Breast Cancer
Award: $0
Institution: University of California, San Francisco Subject Area: Etiology
Role of Chromatin Regulator in Breast Cell Growth
Award: $286,151
Institution: University of California, Davis Subject Area: Biology of the Normal Breast
Tumor Suppression by Dystroglycan in Breast Epithelial Cells
Award: $9,624
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Women with Breast Cancer: Quality of Life and Diet Adherence
Award: $164,427
Institution: University of California, San Diego Subject Area: Sociocultural, Behavioral, and Psychological Issues
Telomere Dynamics during Breast Development
Award: $157,189
Institution: Lawrence Berkeley National Laboratory Subject Area: Biology of the Normal Breast

2000 (Cycle VI)

  Top
Mechanisms of Radiation-Induced Fatigue in Breast Cancer
Award: $224,991
Institution: University of California, Los Angeles Subject Area: Sociocultural, Behavioral, and Psychological Issues
TGF-B3 and small GTPases in Invasive Breast Cancer
Award: $323,925
Institution: Childrens Hospital, Los Angeles Subject Area: Pathogenesis
Analysis of Genes Predictive of Breast Cancer Metastasis
Award: $221,925
Institution: University of California, Davis Subject Area: Pathogenesis
Cell-Based Immunotherapy for Breast Cancer
Award: $120,811
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Novel Mechanisms of ErbB-2-Mediated Breast Cancer Metastasis
Award: $257,006
Institution: Scripps Research Institute Subject Area: Pathogenesis
Tumor Suppression by Dystrogylcan in Breast Epithelial Cells
Award: $181,347
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
Profiling of Tyrosine Phosphatases in Breast Cancer
Award: $133,392
Institution: University of California, Davis Subject Area: Etiology

1999 (Cycle V)

  Top
A Role for RAD51B in Breast Cancer
Award: $406,092
Institution: Lawrence Livermore National Laboratory Subject Area: Pathogenesis
Characterization of hAG-2 and Its Role in Breast Cancer
Award: $166,465
Institution: Stanford University Subject Area: Pathogenesis

1998 (Cycle IV)

  Top
Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy
Award: $419,144
Institution: Sidney Kimmel Cancer Center Subject Area: Innovative Treatments
Dietary Indole Analogs for Breast Cancer Prevention
Award: $435,595
Institution: SRI International Subject Area: Prevention & Risk Reduction
Understanding Breast Cancer Cell Metastasis to Bone
Award: $436,722
Institution: The Burnham Institute for Medical Research Subject Area: Pathogenesis
Heregulin-specific Diphtheria Toxin as a Cancer Therapy
Award: $322,293
Institution: Salk Institute for Biological Studies Subject Area: Innovative Treatments
Multi-ethnic Study of Genetic Control of Plasma Hormones
Award: $141,639
Institution: University of Southern California Subject Area: Etiology
TGF-Beta Receptor Signaling and Breast Cancer
Award: $362,691
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis

1996 (Cycle II)

  Top
Breast Cancer Risk Factors and Hormone Receptors
Award: $271,408
Institution: Kaiser Foundation Research Institute Subject Area: Etiology
IGF-II and cathespin D in tumor growth and metastasis
Award: $353,776
Institution: Loma Linda University Subject Area: Pathogenesis
Analogs of tea polyphenols for breast cancer chemoprevention
Award: $429,092
Institution: SRI International Subject Area: Prevention & Risk Reduction
Architecture of the ErbB2 Molecule Leading to Breast Cancer
Award: $222,349
Institution: University of California, San Francisco Subject Area: Innovative Treatments
BRCA1 regulation in breast cancer: a rat mammary model
Award: $368,159
Institution: University of Southern California Subject Area: Etiology

1995 (Cycle I)

  Top
How Women Decide to Seek Evaluation of Breast Symptoms
Award: $223,588
Institution: University of California, San Francisco Subject Area: Imaging, Biomarkers, & Molecular Pathology
Exercise and the Prevention of Breast Cancer
Award: $367,464
Institution: University of Southern California Subject Area: Prevention & Risk Reduction
Breast Cancer Chemotherapy: Does It Impair Brain Function?
Award: $307,456
Institution: California School of Professional Psychology Subject Area: Innovative Treatments
Loss of p53 Tumor Suppressor Function in Breast Cancer
Award: $313,848
Institution: City of Hope National Medical Center Subject Area: Pathogenesis
False-Positive Mammograms: A Barrier to Annual Screening?
Award: $117,783
Institution: Cancer Prevention Institute of California Subject Area: Imaging, Biomarkers, & Molecular Pathology
Benign Breast Disease, Biopsy & Cancer Preventive Self-Care
Award: $224,351
Institution: University of California, Davis Subject Area: Imaging, Biomarkers, & Molecular Pathology
ErbB2 and Control of Growth in Breast Cancer Cells
Award: $144,936
Institution: University of California, San Diego Subject Area: Pathogenesis
Race/Ethnicity and Late Stage Breast Cancer
Award: $123,127
Institution: University of Southern California Subject Area: Imaging, Biomarkers, & Molecular Pathology
Impact of Physician Attitudes on Mammography Screening Rates
Award: $13,746
Institution: University of California, San Francisco Subject Area: Imaging, Biomarkers, & Molecular Pathology
Determinants of Breast-Conserving Surgery and Survival
Award: $65,235
Institution: Public Health Institute Subject Area: Health Policy & Health Services
Understanding Tamoxifen - A Drug for Breast Cancer
Award: $225,000
Institution: University of California, San Francisco Subject Area: Innovative Treatments
Growth Inhibition of Breast Cancer Cells by Interferons
Award: $225,000
Institution: University of California, Los Angeles Subject Area: Innovative Treatments
Digital Imaging for Hospital and Community Based Mammography
Award: $221,716
Institution: University of California, Los Angeles Subject Area: Imaging, Biomarkers, & Molecular Pathology
The Invasive Nature of Epithelial Breast Cancer Cells
Award: $105,837
Institution: Lawrence Berkeley National Laboratory Subject Area: Pathogenesis
The Invasive Nature of Epithelial Breast Cancer Cells
Award: $269,852
Institution: California Pacific Medical Center Research Institute Subject Area: Pathogenesis
Xenoestrogens and Genetic Damage in Breast Cancer
Award: $159,053
Institution: SRI International Subject Area: Prevention & Risk Reduction